The first battle in the death panel wars is underway and the winner will be declared on December 17. On that day, the Food and Drug Administration will determine whether insurance and Medicare should provide breast cancer patients and their doctors the option of using Avastin -- a late-stage cancer drug that has been proven to extend life. Should the FDA deny coverage for the drug because of its cost, it will be apparent that Krugman and his ilk are winning to battle to ration care in America. Rest assured we are watching the outcome.
 |
via americanthinker.
